Company / Tangible Book Value per Share
GeneDx Holdings Corp. Tangible Book Value per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$10.52
FY2025
5-year range
$9.44 / $3129862.90
FY2021-FY2025
Trend
+11.4%
vs FY2024
Sector context
#50 of 163
Health Care
What the data says
At $10.52, GeneDx Holdings Corp.'s tangible book value per share ranks #50 of 163 in the Health Care sector. Tangible Book Value per Share returned to growth in FY2025 after 3 years of decline, reaching $10.52.
Based on SEC 10-K filings.
10.52 in FY2025 with a 3-year CAGR of -94.0%.
Declined from $19.37 to $10.52 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -94.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#50 of 163 in Health CareTop 31% of 163This company $10.52 Sector average $18.28
▼
-42.5% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share increased 11.4% year-over-year.
- Ranks #50 out of 163 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2021.
- Lowest tangible book value per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -0.67 (distress zone, below 1.8 threshold)
- Negative profit margin: -17.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.52 | +11.4% |
| FY2024 | $9.44 | -51.3% |
| FY2023 | $19.37 | -100.0% |
| FY2022 | $49445.53 | -98.4% |
| FY2021 | $3129862.90 | +4965.7% |
| FY2020 | -$64324.89 | +91.0% |
| FY2019 | -$715411.29 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026